Premier, Inc. PINC
We take great care to ensure that the data presented and summarized in this overview for Premier, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PINC
View all-
Black Rock Inc. New York, NY14.1MShares$394 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$273 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX5.54MShares$154 Million0.03% of portfolio
-
State Street Corp Boston, MA4.26MShares$119 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO3.1MShares$86.3 Million0.04% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA2.39MShares$66.4 Million0.5% of portfolio
-
Geode Capital Management, LLC Boston, MA2.25MShares$62.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.04MShares$56.9 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA1.92MShares$53.5 Million0.01% of portfolio
-
8 Knots Management, LLC Dallas, TX1.69MShares$47.1 Million5.6% of portfolio
Latest Institutional Activity in PINC
Top Purchases
Top Sells
About PINC
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; STOCKD, an e-commerce platform; PROVIDEGX program, which identifies supply sources for drugs that are on or may be at risk of being added to the national drug shortage list, or that are vulnerable to pricing volatility, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company also provides services to other businesses, including food service, schools, and universities. Premier, Inc. was incorporated in 2013 and is headquartered in Charlotte, North Carolina.
Insider Transactions at PINC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 05
2025
|
Andy Brailo Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,581
-5.61%
|
$145,106
$26.29 P/Share
|
Sep 03
2025
|
John T. Bigalke |
SELL
Open market or private sale
|
Direct |
1,137
-3.97%
|
$28,425
$25.79 P/Share
|
Sep 03
2025
|
Andy Brailo Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,521
-6.15%
|
$163,025
$25.79 P/Share
|
Aug 26
2025
|
David L Klatsky General Counsel |
SELL
Open market or private sale
|
Direct |
1,319
-1.38%
|
$32,975
$25.85 P/Share
|
Aug 25
2025
|
Michael J. Alkire President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,335
-2.2%
|
$333,375
$25.7 P/Share
|
Aug 25
2025
|
David L Klatsky General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,607
-1.65%
|
$40,175
$25.7 P/Share
|
Aug 25
2025
|
David L Klatsky General Counsel |
SELL
Open market or private sale
|
Direct |
3,349
-3.33%
|
$83,725
$25.57 P/Share
|
Aug 25
2025
|
Andy Brailo Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,770
-1.64%
|
$44,250
$25.7 P/Share
|
Aug 25
2025
|
Crystal Climer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
425
-0.82%
|
$10,625
$25.7 P/Share
|
Aug 23
2025
|
Michael J. Alkire President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,558
-1.71%
|
$263,950
$25.14 P/Share
|
Aug 23
2025
|
David L Klatsky General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,272
-1.25%
|
$31,800
$25.14 P/Share
|
Aug 23
2025
|
Andy Brailo Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,453
-1.33%
|
$36,325
$25.14 P/Share
|
Aug 23
2025
|
Crystal Climer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,488
-2.78%
|
$37,200
$25.14 P/Share
|
Aug 22
2025
|
Michael J. Alkire President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,334
-2.58%
|
$408,350
$25.14 P/Share
|
Aug 22
2025
|
David L Klatsky General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,805
-2.68%
|
$70,125
$25.14 P/Share
|
Aug 22
2025
|
Andy Brailo Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,622
-2.35%
|
$65,550
$25.14 P/Share
|
Aug 22
2025
|
Crystal Climer Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
661
-0.61%
|
$16,525
$25.14 P/Share
|
Aug 22
2025
|
Crystal Climer Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,082
+1.96%
|
$27,050
$25.14 P/Share
|
Aug 21
2025
|
Crystal Climer Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,161
+8.86%
|
-
|
Aug 21
2025
|
Andy Brailo Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,173
+11.95%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 569K shares |
---|
Payment of exercise price or tax liability | 61.9K shares |
---|---|
Open market or private sale | 173K shares |